ASX Announcements
Becoming a substantial holder
Application for quotation of securities - OPT
Appendix 2A (Application for Quotation of Securities)
Application for quotation of securities - OPT
Appendix 2A (Application for Quotation of Securities)
This Month
It’s Phil King’s Regal against the shorts at biotech play Opthea
The high-profile stockpicker is the eye disorder treatment hopeful’s biggest shareholder. Ahead of the results of a crucial clinical trial, shorts are rising.
June 2024
Opthea launches $220 million capital raising, MST on ticket
The biotech has high hopes for a new drug that if successful could treat macular degeneration.
April 2024
Why picking ASX biotechs is mostly for the crazy brave
It’s a space with a reputation for rollercoaster returns and outlandish sales pitches, but some investors get lucky.
October 2022
The cash clues that suggest Dreamworld owner is wildly undervalued
Pengana’s James McDonald is tipping into Aussie names Telix and Opthea, potash producer K+S, and the valuation case for Ardent at 70¢.
August 2022
Carlyle chases potential four-bagger at biotech Opthea
The Carlyle Group and its newly acquired life sciences arm Abingworth are chasing a four-bagger at Australian eye therapies developer Opthea.
Eye therapies group Opthea in $US240m funding deal, chases equity leg
It’s a big day for ASX-listed Opthea, an eye therapies developer with a near $500 million market capitalisation.
October 2020
ASX gains 1.2pc for week; Aussie Broadband soars 91pc
The Australian sharemarket notched up a second week of gains even as the S&P/ASX200 Index fell 0.5 per cent on Friday. Afterpay closed at a record high. Aussie Broadband surged on debut. Tyro gained 6 per cent on a deal with Bendigo Bank.
ASX gains; Six day winning streak as banks bounce; Link soars
The Australian sharemarket notched up a sixth straight days of gains as banks rallied off their session lows. Carlyle and Pacific Equity Partners offered $5.20 a share for Link. Aware Super raised its bid for OptiComm to $6.50 a share. Bravura bought UK-based Delta for $41.5 million.
September 2020
Banks rally lifts stocks to best week since mid-August
The sharemarket advanced 1.7 per cent over the week as banks enjoyed a massive rally on Friday. Westpac's 7 per cent surge helped steer the S&P/ASX200 Index 1.5 per cent higher on Friday as the government moved to relax responsible lending rules.
June 2020
Momentum builds for small cap biotechs
Australian Ethical's Andy Gracey likes companies that have real signs of efficacy and are no longer in the petri dish.
November 2019
Healthcare stocks tipped for strong 2020 as clinical trial results pour in
Investors have returned to the big life sciences companies as growth in other sectors has slowed, says Morgans.
September 2019
Small cap healthcare stocks surge to billion-dollar plays
Successful results from a handful of emerging biotech companies have shifted investor sentiment about the sector.